Your browser does not support iframes.
The Modesto Bee Local Stock Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Merck & Co., Inc.
(NY:
MRK
)
46.71
USD
-0.62 (-1.31%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
42,629,592
Open
47.60
Bid (Size)
46.65 (100)
Ask (Size)
46.70 (300)
Prev. Close
47.33
Today's Range
46.49 - 48.30
52wk Range
37.02 - 48.79
Shares Outstanding
3,019,611,844
Dividend Yield
3.64%
Top News
More News
Don't Miss Gains in C, MRK, NTAP and NOK
Today 3:00 EDT
from
Marketwired News Releases
Pfizer takes its shot at a vaccine for evasive superbug
Today 1:20 EDT
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...
Read More
from
FOX News
More News
Read More
UPDATE 2-Merck's insomnia drug moves a step closer to U.S. approval
May 22, 2013
category
companyNews
from
Reuters: Company News
Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant
May 22, 2013
category
Management
,
Benzinga
,
Guidance
, and 3 more.
from
Latest Articles from Benzinga.com
UPDATE 1-FDA panel says Merck's sleep drug safe, effective at lower dose
May 22, 2013
category
companyNews
from
Reuters: Company News
Merck Statement on FDA Advisory Committee Meeting for Suvorexant
May 22, 2013
from
Business Wire News Releases
FDA panel: Merck's insomnia drug effective, safe at low doses
May 22, 2013
category
companyNews
from
Reuters: Company News
Merck's (MRK) Suvorexant Helps People Sleep, Says FDA
May 22, 2013
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 5/22: (ZLC) (SKS) (TOL) Higher; (UAN) (TGT) (SODA) Lower (more...)
May 22, 2013
from
StreetInsider.com News Articles
Stocks Open Higher Ahead of Bernanke Testimony
May 22, 2013
category
Economics
,
Merck & Co Inc
,
Boeing Co
, and 13 more.
from
CNBC.com News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.